Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic.
Abanoub Riad, Andrea Pokorná, Sameh Attia...
https://pubmed.ncbi.nlm.nih.gov/33916020/Actively Recruiting
Led by Masaryk University · Updated on 2022-04-06
30000
Participants Needed
14
Research Sites
52 weeks
Total Duration
Researchers are actively monitoring the side effects of COVID-19 vaccines worldwide in healthcare workers, adults over 65, and schoolteachers. The study aims to estimate how common local and systemic side effects are for each vaccine brand, identify demographic and medical factors influencing side effects, and evaluate long-term consequences. It also compares the relative safety of different COVID-19 vaccines and examines how palliative drugs affect short-term side effect resolution. The project has two phases a cross-sectional survey and a prospective cohort study. Phase A uses an online questionnaire to collect information about short-term side effects occurring within 30 days after vaccination, covering either the first or second dose. Phase B follows volunteers interested in reporting long-term side effects and vaccine effectiveness after booster doses over five years, starting in 2022. Multiple COVID-19 vaccines are included, such as Pfizer-BioNTech, Moderna, AstraZeneca, Sinovac, Sinopharm, Sputnik V, Janssen, CureVac, Novavax, and Covaxin. Participants provide self-reported data through validated online questionnaires about side effect onset, duration, and intensity. The study tracks local and systemic side effects within 30 days post-vaccination as primary outcomes, with unrecognized side effects as secondary outcomes. Volunteers are followed for long-term safety and vaccine effectiveness, with a total observation period extending up to five years. This ongoing monitoring helps researchers understand vaccine safety profiles and side effect patterns in different populations.
CONDITIONS
COVID-19 Vaccines Safety Tracking (CoVaST)
M
Miloslav Klugar, PhD
A
Abanoub Riad, DDS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Masaryk University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (online)
Duration - 30 days
Participants complete a self-administered online questionnaire to report short-term side effects occurring within 30 days after receiving a COVID-19 vaccine dose.
1 online questionnaire within 30 days after vaccination
Duration - 5 years
Participants who consent continue to report long-term side effects and vaccine effectiveness after booster doses using online questionnaires over five years.
Periodic online questionnaires after booster doses
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
11
Have more questions? Get in touch with our team for quick support
Abanoub Riad, Andrea Pokorná, Sameh Attia...
https://pubmed.ncbi.nlm.nih.gov/33916020/Abanoub Riad, Holger Schünemann, Sameh Attia...
https://pubmed.ncbi.nlm.nih.gov/34360156/Masaryk University
Lead Sponsor